Positive clinical results of Palobiofarma´s adenosine A1 antagonist PBF-680 presented at the European Respiratory Society meeting

by Palobiofarma

6 years ago
oral asthma therapy, allergen, adenosine

The results of an allergen POC trial in asthmatics will summarized by Dr. David Ramos, principal investigator of the PBF-680 clinical program, in an oral presentation titled:

Unveiled the nature of the ligand of Pru p 3, the major allergen from peach

by Centro de Biotecnología y Genómica de Plantas CBGP

9 years ago
Pru p 3, food allergy, allergen, peach

Pru p 3 is the major allergen from peach, fruit which is among the most frequent causes of food allergy in the Mediterranean population. Although this lipid transfer protein has been well studied, its...